Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System

OBJECTIVE: The MiniMed 670G System is the first commercial hybrid closed-loop (HCL) system for management of type 1 diabetes. Using data from adolescent and young adult participants, we compared insulin delivery patterns and time-in-range metrics in HCL (Auto Mode) and open loop (OL). System alerts,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Care
Autors principals: Messer, Laurel H., Forlenza, Gregory P., Sherr, Jennifer L., Wadwa, R. Paul, Buckingham, Bruce A., Weinzimer, Stuart A., Maahs, David M., Slover, Robert H.
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2018
Matèries:
Emerging Technologies and Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6463622/
https://ncbi.nlm.nih.gov/pubmed/29444895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc17-1682
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars